)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Nxera Pharma (4565) investor relations material
Nxera Pharma Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary8 Aug, 2025
Executive summary
Net sales/revenue rose 19% year-over-year to JPY 15,094 million–JPY 150B, driven by PIVLAZ, QVIVIC/QUVIVIQ, and milestone payments.
Commercial performance anchored by PIVLAZ and QVIVIC/QUVIVIQ, with PIVLAZ net sales up 7.6–9% and QVIVIC contributing new revenue.
R&D pipeline advanced with new obesity/metabolic programs, key clinical milestones, and expanded partnerships.
Net loss narrowed to JPY 3,137 million from JPY 4,703 million year-over-year, reflecting higher revenue and lower SG&A.
Strategic focus on neurology, metabolic, and immunology/GI diseases, aiming for high growth and profitability by 2030.
Financial highlights
Revenue/net sales increased 18.7–19% year-over-year to JPY 15,094 million–JPY 150B, led by PIVLAZ and QVIVIC.
Core operating profit for H1 was JPY 300–364 million, down from JPY 1.1–1.2B last year due to higher R&D spend.
Operating loss improved to JPY 2,756 million from JPY 3,654 million year-over-year.
R&D expenses increased 47% year-over-year to JPY 7,474 million; SG&A expenses decreased 6%.
Milestone and upfront payments included USD 10M from Viatris and USD 15M from Neurocrine.
Outlook and guidance
FY2025 sales targets: PIVLAZ/QUVIVIQ JPY 17B+; PIVLAZ JPY 13–14B; QVIVIC/QUVIVIQ JPY 4–5B; R&D JPY 12–14B; SG&A JPY 15–17B.
R&D and SG&A expense forecasts unchanged; R&D costs expected to moderate in H2.
No full-year forecast due to unpredictability of milestone payments.
Focus on in-licensing late-stage assets and expanding the pipeline.
Long-term goal to reach JPY 50B core revenue by FY2029, a 25% CAGR from 2023.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Nxera Pharma earnings date
Q3 202531 Oct, 2025
Next Nxera Pharma earnings date
Q3 202531 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Sosei Group Corporation, also known as Sosei Heptares, is a biopharmaceutical company that specializes in the development of drugs using its proprietary G protein-coupled receptor (GPCR) targeted StaR technology and structure-based drug discovery (SBDD) platform. The company's product lineup includes medicines such as Ultibro, Seebri, Enerzair, Breezhaler, Pivlaz, and Oravi. Sosei Group Corporation is headquartered in Chiyoda-ku, Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage